Global Non-Alcoholic Steatohepatitis Market is Expected To Be Worth US$ 20 Billion By 2025

The increase in the cycles of clinical trials with growing success rates is expected to increase the chances of getting a commercial approval by 2017 which is driving the market. However, the unexplained and complex physiological structure and inefficient diagnostics technology which lengthens the commercialization of non-alcoholic steatohepatitis therapeutics are expected to hamper the growth of the non-alcoholic steatohepatitis market.

The global non-alcoholic steatohepatitis market is expected to reach more than US$ 20 billion by 2025, registering a compound annual growth rate (CAGR) of more than 10% during the forecast period.

A glimpse of the report structure is provided in the report description available on the website.
https://www.marketresearchengine.com/reportdetails/non-alcoholic-steatohepatitis-nash-market

Genfit SA (France), Gilead Sciences (U.S.), Novo Nordisk A/S (Denmark), Intercept Pharmaceuticals (U.S.), Enzo Biochem, Inc. (U.S.), and Raptor Pharmaceutical Corp. (U.S.) are the most active players in the non-alcoholic steatohepatitis market.

In this report, the global non-alcoholic steatohepatitis market is segmented on the basis of therapeutics and region. The market on the basis of therapeutics is segmented into GFT505, obeticholic acid (INT-747), liraglutide (victoza) and simtuzumab, vitamin E, pioglitazone, and placebo.

The global non-alcoholic steatohepatitis market is segmented on the basis of key regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is the largest non-alcoholic steatohepatitis market. The market in Asia Pacific is projected to register the highest double digit CAGR during the forecast period. This high growth is attributed to the increasing occurrence of non-alcoholic fatty liver diseases in the densely populated developing countries such as India, South Korea, and China. Furthermore, each region is segmented to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, India, Brazil, and GCC countries. The report includes a detailed study of the global and regional market for various types of non-alcoholic steatohepatitis and analyzes the variations in the growth of the industry in certain regions.

This report covers the non-alcoholic steatohepatitis market, in terms of value, and forecasts the market size till 2025. In addition, the report identifies key growth segments and opportunities in the industry. This report also covers detailed competitive outlook including the share and company profiles of the key players in the global non-alcoholic steatohepatitis market. Company profile includes company summary, financial summary, business strategy and planning, SWOT analysis, and current developments.

Request Free Sample Report: https://www.marketresearchengine.com/reportdetails/non-alcoholic-steatohepatitis-nash-market

The deep-dive study on the non-alcoholic steatohepatitis market will help customers with the identification of new market opportunities and targeted promotional plans.

Table of Contents

1 Introduction
2 EXECUTIVE SUMMARY
3 MARKET OVERVIEW
4 GLOBAL NONALCOHOLIC STEATOHEPATITIS MARKET BY DRUG TYPES
5 GLOBAL NONALCOHOLIC STEATOHEPATITIS MARKET (PIPELINE DRUG ANALYSIS)BY GEOGRAPHY, 2013-2020
6 COMPANY PROFILES
6.1 Genfit
6.2 Gilead Science
6.3 Novo Nordisk
6.4 Intercepts Pharmaceuticals
6.5 Enzo Biochem, Inc.
6.6 Raptor Pharmaceutical Corp.

About Us

Market Research Engine (MRE) is a next-generation provider of syndicated research, customized research, and consulting services. MRE’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each Market Research Engine’s research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.